Redeye states Sivers Q4'22 report and guidance was largely inline with our estimates. Hence, we have not updated our estimates. Considering the development agreement for the SATCOM business and the expected ramp-up in the Photonics segment we continue to view the shares favorably.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking.

© Modular Finance, source Nordic Press Releases